Autor: | Joanne M. Hilden, Darryl C. Longee, Bernd W. Scheithauer, Joanne Kurtzberg, Jan Watterson, Christopher L. Moertel, Mary Elizabeth Dunn |
---|---|
Rok vydání: | 1998 |
Předmět: |
Medulloblastoma
Cancer Research Chemotherapy medicine.medical_specialty business.industry medicine.medical_treatment medicine.disease Surgery Central nervous system disease Radiation therapy Teratoid tumor Neurology Oncology Localized disease medicine Neurology (clinical) Teratoma business Progressive disease |
Zdroj: | Journal of Neuro-Oncology. 40:265-275 |
ISSN: | 0167-594X |
DOI: | 10.1023/a:1006125120866 |
Popis: | Central nervous system atypical teratoid/rhabdoid tumor (ATT/RT) of infancy and childhood is a unique histologic entity with an extremely aggressive natural history. Standard therapy for infant and childhood medulloblastoma, for which this entity is often mistaken, has been ineffective; most children survive less than 12 months after diagnosis. Intensified therapy has been recently used for children with this disease, with promising results [1,2]. We report four cases of ATT/RT in young children; all had subtotal resections and localized disease at diagnosis. One child treated prior to bone marrow transplant availability died of progressive disease 9 months after diagnosis. Another child, treated with high-dose chemotherapy and radiotherapy in preparation for bone marrow transplant, had a recurrence and died 20 months after diagnosis, without undergoing the transplant. Two children received high-dose chemotherapy and autologous bone-marrow transplant and had a good response to treatment; one survived 19 months, the other child is free of disease 46 months from diagnosis. Intensified therapy has altered the natural history of central nervous system ATT/RT. |
Databáze: | OpenAIRE |
Externí odkaz: |